Common use of Subsidiaries Clause in Contracts

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 534 contracts

Sources: Securities Purchase Agreement (Benitec Biopharma Inc.), Securities Purchase Agreement (Intensity Therapeutics, Inc.), Securities Purchase Agreement (MultiSensor AI Holdings, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries Subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiariesSubsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 198 contracts

Sources: Common Stock Purchase Agreement (MultiSensor AI Holdings, Inc.), Underwriting Agreement (CPS Technologies Corp/De/), Underwriting Agreement (Artelo Biosciences, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 105 contracts

Sources: Securities Purchase Agreement (Datavault AI Inc.), Securities Purchase Agreement (Wellgistics Health, Inc.), Securities Purchase Agreement (Wellgistics Health, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Except as set forth in the SEC Reports, the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 49 contracts

Sources: Securities Purchase Agreement (Aptorum Group LTD), Securities Purchase Agreement (GeoVax Labs, Inc.), Securities Purchase Agreement (Tharimmune, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in on the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 22 contracts

Sources: Securities Purchase Agreement (Clean Vision Corp), Securities Purchase Agreement (SRIVARU Holding LTD), Securities Purchase Agreement (Clean Vision Corp)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC ReportsReports or have otherwise been disclosed to Purchasers by the Company. The Company owns, directly or indirectly, all of the its capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 17 contracts

Sources: Securities Purchase Agreement (Marpai, Inc.), Securities Purchase Agreement (Marpai, Inc.), Securities Purchase Agreement (ALT5 Sigma Corp)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, paid and non-assessable and free of preemptive and similar rights to subscribe for or purchase securitiesassessable. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 16 contracts

Sources: Securities Purchase Agreement (AIFU Inc.), Securities Purchase Agreement (Maase Inc.), Securities Purchase Agreement (MingZhu Logistics Holdings LTD)

Subsidiaries. All of the direct and indirect subsidiaries Subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 16 contracts

Sources: Securities Purchase Agreement (Robin Energy Ltd.), Underwriting Agreement (Robin Energy Ltd.), Underwriting Agreement (OceanPal Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Except as disclosed in the SEC Reports, (i) the Company owns, directly or indirectly, all of the share capital stock or other equity interests of each Subsidiary free and clear of any Liens, Liens and (ii) all of the issued and outstanding shares of share capital stock of each Subsidiary are validly issued and are fully paid, paid and are not subject to any calls for additional payments (non-assessable assessable) and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 11 contracts

Sources: Securities Purchase Agreement (Iterum Therapeutics PLC), Securities Purchase Agreement (Iterum Therapeutics PLC), Securities Purchase Agreement (Iterum Therapeutics PLC)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary which it owns, free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 9 contracts

Sources: Securities Purchase Agreement (Aethlon Medical Inc), Securities Purchase Agreement (Aethlon Medical Inc), Securities Purchase Agreement (XCel Brands, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth Except as disclosed in the SEC Reports, the Company has no direct or indirect subsidiaries. The Except as disclosed in the SEC Reports, the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securitiesrights. If the Company has no subsidiaries, all other then references to the Subsidiaries or any of them in the Transaction Documents shall to the Subsidiaries will be disregarded.

Appears in 8 contracts

Sources: Securities Purchase Agreement (San Holdings Inc), Securities Purchase Agreement (Focus Enhancements Inc), Securities Purchase Agreement (San Holdings Inc)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary which it owns, free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 7 contracts

Sources: Securities Purchase Agreement (Castellum, Inc.), Securities Purchase Agreement (Yield10 Bioscience, Inc.), Securities Purchase Agreement (Yield10 Bioscience, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries Subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 7 contracts

Sources: Securities Purchase Agreement (Petros Pharmaceuticals, Inc.), Securities Purchase Agreement (Petros Pharmaceuticals, Inc.), Securities Purchase Agreement (Petros Pharmaceuticals, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries Subsidiaries of the Company required to be referenced in the SEC Reports are set forth in on the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 6 contracts

Sources: Securities Purchase Agreement (Superconductor Technologies Inc), Securities Purchase Agreement (Superconductor Technologies Inc), Securities Purchase Agreement (Superconductor Technologies Inc)

Subsidiaries. All of the direct and indirect subsidiaries Subsidiaries of the Company are set forth in on the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 6 contracts

Sources: Underwriting Agreement (Superconductor Technologies Inc), Underwriting Agreement (Superconductor Technologies Inc), Underwriting Agreement (Superconductor Technologies Inc)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary Subsidiary, free and clear of any Liens, except as set for in the SEC Reports and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 5 contracts

Sources: Securities Purchase Agreement (180 Life Sciences Corp.), Securities Purchase Agreement (Zivo Bioscience, Inc.), Securities Purchase Agreement (SELLAS Life Sciences Group, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in on the applicable exhibits filed with the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 5 contracts

Sources: Securities Purchase Agreement (Pladeo Corp.), Securities Purchase Agreement (Advaxis, Inc.), Securities Purchase Agreement (Max Sound Corp)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the Company’s SEC Reportsfilings. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any LiensSubsidiary, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 5 contracts

Sources: Securities Purchase Agreement (Renavotio, Inc.), Securities Purchase Agreement (Renavotio, Inc.), Securities Purchase Agreement (Renavotio, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries Subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests Company’s ownership and control of each Subsidiary free and clear of any Liensis as described in the SEC Reports, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiariesSubsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 4 contracts

Sources: Underwriting Agreement (NutriBand Inc.), Underwriting Agreement (LabStyle Innovations Corp.), Underwriting Agreement (LabStyle Innovations Corp.)

Subsidiaries. All of the significant direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 4 contracts

Sources: Securities Purchase Agreement (New Generation Biofuels Holdings, Inc), Securities Purchase Agreement (New Generation Biofuels Holdings, Inc), Securities Purchase Agreement (New Generation Biofuels Holdings, Inc)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are as set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 4 contracts

Sources: Securities Purchase Agreement (NexImmune, Inc.), Note Purchase Agreement (Mateon Therapeutics Inc), Note Purchase Agreement (Marina Biotech, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in on the SEC ReportsReports or listed on Schedule 3.1(a). The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 4 contracts

Sources: Securities Purchase Agreement (NRX Pharmaceuticals, Inc.), Securities Purchase Agreement (NRX Pharmaceuticals, Inc.), Securities Purchase Agreement (InMed Pharmaceuticals Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Except as disclosed in the SEC Reports, the Company owns, directly or indirectly, all of the share capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of share capital stock of each Subsidiary are validly issued and are fully paid, paid and are not subject to any calls for additional payments (non-assessable assessable) and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 4 contracts

Sources: Securities Purchase Agreement (Nabriva Therapeutics PLC), Securities Purchase Agreement (Nabriva Therapeutics PLC), Securities Purchase Agreement (Nabriva Therapeutics PLC)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary Subsidiary, free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 4 contracts

Sources: Securities Purchase Agreement (NeuroSense Therapeutics Ltd.), Securities Purchase Agreement (Motorsport Games Inc.), Securities Purchase Agreement (Stardust Power Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the share capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of share capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 4 contracts

Sources: Securities Purchase Agreement (VCI Global LTD), Securities Purchase Agreement (Altamira Therapeutics Ltd.), Securities Purchase Agreement (Altamira Therapeutics Ltd.)

Subsidiaries. All of the direct and indirect principal subsidiaries of the Company are set forth in the SEC Reports. The Except as set forth on Schedule 3.1(a), the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 4 contracts

Sources: Securities Purchase Agreement (Tian Ruixiang Holdings LTD), Securities Purchase Agreement (Tian Ruixiang Holdings LTD), Securities Purchase Agreement (Ebang International Holdings Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 4 contracts

Sources: Securities Purchase Agreement (Meten Holding Group Ltd.), Securities Purchase Agreement (Meten Holding Group Ltd.), Securities Purchase Agreement (Greenland Technologies Holding Corp.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the share capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 3 contracts

Sources: Securities Purchase Agreement (SaverOne 2014 Ltd.), Securities Purchase Agreement (Mobilicom LTD), Securities Purchase Agreement (Steakholder Foods Ltd.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the Company’s SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 3 contracts

Sources: Securities Purchase Agreement (Vivakor, Inc.), Securities Purchase Agreement (Vivakor, Inc.), Securities Purchase Agreement (Vivakor, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries (“Subsidiaries”) of the Company Company, if any, are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 3 contracts

Sources: Securities Purchase Agreement (Tenon Medical, Inc.), Securities Purchase Agreement (Tenon Medical, Inc.), Securities Purchase Agreement (Tenon Medical, Inc.)

Subsidiaries. All of the material direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Except as set forth in the SEC Reports, the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 3 contracts

Sources: Securities Purchase Agreement (Apexigen, Inc.), Securities Purchase Agreement (NovaBay Pharmaceuticals, Inc.), Securities Purchase Agreement (NovaBay Pharmaceuticals, Inc.)

Subsidiaries. All of the direct and indirect principal subsidiaries of the Company are set forth in the SEC Reports. The Except as set forth in the SEC Reports, the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 3 contracts

Sources: Securities Purchase Agreement (Ebang International Holdings Inc.), Securities Purchase Agreement (Ebang International Holdings Inc.), Securities Purchase Agreement (Ebang International Holdings Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC ReportsReports as filed with the Commission. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other then references to the Subsidiaries or any of them in the Transaction Documents shall to the Subsidiaries will be disregarded.

Appears in 3 contracts

Sources: Securities Purchase Agreement (Wave Systems Corp), Securities Purchase Agreement (Wave Systems Corp), Securities Purchase Agreement (Eagle Broadband Inc)

Subsidiaries. All of the direct and indirect subsidiaries Subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiariesSubsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 3 contracts

Sources: Securities Purchase Agreement (Genprex, Inc.), Securities Purchase Agreement (Pineapple Financial Inc.), Underwriting Agreement (Biomerica Inc)

Subsidiaries. All of the direct and indirect subsidiaries Subsidiaries of the Company are set forth in the Company’s SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 3 contracts

Sources: Underwriting Agreement (Ceres, Inc.), Underwriting Agreement (Ceres, Inc.), Underwriting Agreement (Ceres, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any LiensSubsidiary, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 3 contracts

Sources: Securities Purchase Agreement (Petros Pharmaceuticals, Inc.), Securities Purchase Agreement (Petros Pharmaceuticals, Inc.), Securities Purchase Agreement (Petros Pharmaceuticals, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC ReportsReports (as defined below). The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 3 contracts

Sources: Securities Purchase Agreement (Next Technology Holding Inc.), Securities Purchase Agreement (xG TECHNOLOGY, INC.), Securities Purchase Agreement (xG TECHNOLOGY, INC.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Except as disclosed in the SEC Reports, the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 3 contracts

Sources: Securities Purchase Agreement (Nautilus, Inc.), Securities Purchase Agreement (Marathon Patent Group, Inc.), Securities Purchase Agreement (Marathon Patent Group, Inc.)

Subsidiaries. All of the material direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 3 contracts

Sources: Securities Purchase Agreement (Chicken Soup for the Soul Entertainment, Inc.), Securities Purchase Agreement (Actinium Pharmaceuticals, Inc.), Securities Purchase Agreement (Avalon Rare Metals Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the its capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 3 contracts

Sources: Securities Purchase Agreement (Rezolve Ai PLC), Securities Purchase Agreement (ALT5 Sigma Corp), Securities Purchase Agreement (Rezolve Ai PLC)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Unless otherwise indicated in the SEC Reports, the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paidpaid (to the extent it is required by its jurisdiction of incorporation), non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 2 contracts

Sources: Securities Purchase Contract (Nano Labs LTD), Securities Purchase Contract (Nano Labs LTD)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock shares or other equity interests of each Subsidiary Subsidiary, free and clear of any Liens, except as set forth in the SEC Reports, and all of the issued and outstanding shares of capital stock shares of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 2 contracts

Sources: Securities Purchase Agreement (Chemomab Therapeutics Ltd.), Securities Purchase Agreement (MeaTech 3D Ltd.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Except as set forth in the SEC Reports, the Company owns, directly or indirectly, all of the share capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of share capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 2 contracts

Sources: Securities Purchase Agreement (XORTX Therapeutics Inc.), Securities Purchase Agreement (XORTX Therapeutics Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Except as set forth on Schedule 3.1(a), the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 2 contracts

Sources: Securities Purchase Agreement (Purple Biotech Ltd.), Securities Purchase Agreement (Scinai Immunotherapeutics Ltd.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth described in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 2 contracts

Sources: Exchange Agreement (Edible Garden AG Inc), Securities Purchase Agreement (Wave Systems Corp)

Subsidiaries. All of the direct and indirect principal subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 2 contracts

Sources: Securities Purchase Agreement (VivoPower International PLC), Securities Purchase Agreement (VivoPower International PLC)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in on the SEC Reports). The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 2 contracts

Sources: Securities Purchase Agreement (Olb Group, Inc.), Securities Purchase Agreement (Olb Group, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company Company, if any, are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the share capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 2 contracts

Sources: Securities Purchase Agreement (Vs MEDIA Holdings LTD), Securities Purchase Agreement (Vs MEDIA Holdings LTD)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth as disclosed in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 2 contracts

Sources: Securities Purchase Agreement (Rubini Jonathan Brian), Securities Purchase Agreement (G Medical Innovations Holdings Ltd.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth on in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 2 contracts

Sources: Securities Purchase Agreement (Force Protection Video Equipment Corp.), Securities Purchase Agreement (Force Protection Video Equipment Corp.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC ReportsReports or set forth on Schedule 3.1. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 2 contracts

Sources: Securities Purchase Agreement (60 Degrees Pharmaceuticals, Inc.), Securities Purchase Agreement (60 Degrees Pharmaceuticals, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in on the SEC Reports. .The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 2 contracts

Sources: Securities Purchase Agreement (InMed Pharmaceuticals Inc.), Securities Purchase Agreement (InMed Pharmaceuticals Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock share or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock share of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 2 contracts

Sources: Securities Purchase Agreement (Stellar Biotechnologies, Inc.), Securities Purchase Agreement (Stellar Biotechnologies, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 2 contracts

Sources: Securities Purchase Agreement (Datasea Inc.), Securities Purchase Agreement (AppTech Payments Corp.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall will be disregarded.

Appears in 2 contracts

Sources: Securities Purchase Agreement (SenesTech, Inc.), Securities Purchase Agreement (SenesTech, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries Subsidiaries of the Company are set forth disclosed in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 2 contracts

Sources: Securities Purchase Agreement (Cyclacel Pharmaceuticals, Inc.), Securities Purchase Agreement (Cyclacel Pharmaceuticals, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries (individually, a “Subsidiary”) of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, Liens and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiariesSubsidiaries, all other references to the Subsidiaries or any of them in this Agreement or any other documents or agreements executed in connection with the Transaction Documents transactions contemplated hereunder shall be disregarded.

Appears in 2 contracts

Sources: At the Market Offering Agreement (Hancock Jaffe Laboratories, Inc.), At the Market Offering Agreement (Sonoma Pharmaceuticals, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the IN IT'S SEC ReportsREPORTS AS FILED WITH THE COMMISSION. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other then references to the Subsidiaries or any of them in the Transaction Documents shall to the Subsidiaries will be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Wave Systems Corp)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any lien, charge, security interest, encumbrance, right of first refusal or other restriction (collectively, "Liens"), and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securitiesrights. If the Company has no subsidiaries, all other then references to the Subsidiaries or any of them in the Transaction Documents shall to the Subsidiaries will be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Pharmos Corp)

Subsidiaries. All of the direct and indirect material subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Ekso Bionics Holdings, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are as set forth in the SEC Reports. The Except as set forth in the SEC Reports, the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Bellerophon Therapeutics, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Except as set forth in Schedule 3.1(a), the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Beyond Air, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents this Agreement shall be disregarded.

Appears in 1 contract

Sources: Underwriting Agreement (Foresight Autonomous Holdings Ltd.)

Subsidiaries. All of the direct and indirect subsidiaries Subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock shares or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock shares of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiariesSubsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents this Agreement shall be disregarded.

Appears in 1 contract

Sources: Underwriting Agreement (Zomedica Corp.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC and TASE Reports. The Company owns, directly or indirectly, all of the capital stock shares or other equity interests of each Subsidiary Subsidiary, free and clear of any Liens, and all of the issued and outstanding shares of capital stock shares of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Brainsway Ltd.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in on the SEC Reports, other than newly formed subsidiary ▇▇▇▇ ▇▇▇ Universe, LLC, which has no assets or operations. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Genius Brands International, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company as of the date hereof are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary owned by the Company are owned free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other then references to the Subsidiaries or any of them in the Transaction Documents shall to the Subsidiaries will be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Generex Biotechnology Corp)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock share or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock share of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Aptose Biosciences Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the shares capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of share capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Diginex LTD)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are Except as set forth in the SEC Reports. The , the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Pineapple Energy Inc.)

Subsidiaries. All of the direct and indirect subsidiaries Subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable assessable, and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiariesSubsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Underwriting Agreement (Tenon Medical, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth Except as disclosed in the SEC Reports. The , the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (UpHealth, Inc.)

Subsidiaries. All of the The Company has no direct and or indirect subsidiaries of the Company are set forth other than those specified in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (India Globalization Capital, Inc.)

Subsidiaries. All of the material direct and indirect subsidiaries Subsidiaries of the Company are set forth disclosed in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Superconductor Technologies Inc)

Subsidiaries. All of the direct and indirect subsidiaries Subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Processa Pharmaceuticals, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock share or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock share of each Subsidiary are validly issued and are issued, fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (CollPlant Biotechnologies LTD)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive pre-emptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (NLS Pharmaceutics Ltd.)

Subsidiaries. All of the direct and indirect subsidiaries Subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the share capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (OXBRIDGE RE HOLDINGS LTD)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in on the SEC Reports. The Company owns, directly or indirectly, all of the capital stock share or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Creative Realities, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries Subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the share capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiariesSubsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Underwriting Agreement (Ohmyhome LTD)

Subsidiaries. All of the direct and indirect subsidiaries Subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable nonassessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiariesSubsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Underwriting Agreement (Plus Therapeutics, Inc.)

Subsidiaries. All of the direct and indirect The Company’s subsidiaries of the Company are set forth disclosed in an exhibit to the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Myos Rens Technology Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth disclosed in the SEC Reports. The Except as disclosed in the SEC Reports, the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Pulmatrix, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.. ​ ​

Appears in 1 contract

Sources: Securities Purchase Agreement (Agile Therapeutics Inc)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, then all other references in the Transaction Documents to the Subsidiaries or any of them in the Transaction Documents shall will be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Neurobiological Technologies Inc /Ca/)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. Other than Fuel Tech S.r.L., no Subsidiary of the Company is operational. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Fuel Tech, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth as included in the SEC Reports. The Except as specified in the SEC Reports, the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Authentidate Holding Corp)

Subsidiaries. All of the direct and indirect subsidiaries of the Company Company, if any, are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Aclarion, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC ReportsReports (as hereinafter defined). The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Check-Cap LTD)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the share capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of share capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Virax Biolabs Group LTD)

Subsidiaries. All of the direct and indirect subsidiaries Subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock shares or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares or shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiariesSubsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Underwriting Agreement (GLORY STAR NEW MEDIA GROUP HOLDINGS LTD)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of share capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Medigus Ltd.)

Subsidiaries. All of the direct and indirect subsidiaries Subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the share capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of share capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiariesSubsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (XORTX Therapeutics Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are as set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-non- assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Healthcare Triangle, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Except as set forth SEC Reports, the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Enveric Biosciences, Inc.)

Subsidiaries. All of the direct and indirect subsidiaries Subsidiaries of the Company are set forth in the SEC Reports. The Except as set forth in the SEC Reports, the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiariesSubsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Abeona Therapeutics Inc.)

Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC ReportsReports or have otherwise been disclosed to Purchasers by the Company. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paidduly paid in accordance with its respective articles of association, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them except as otherwise disclosed in the Transaction Documents shall be disregardedSEC Reports.

Appears in 1 contract

Sources: Securities Purchase Agreement (Boqii Holding LTD)

Subsidiaries. All of the significant direct and indirect subsidiaries Subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiariesSubsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Underwriting Agreement (Societal CDMO, Inc.)

Subsidiaries. All of the direct and indirect significant subsidiaries of the Company are set forth in the SEC Reports. The Except as set forth in the SEC Reports, the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (NAKED BRAND GROUP LTD)

Subsidiaries. All of the direct and indirect subsidiaries of the Company required to be disclosed in the SEC Reports are set forth disclosed in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens (other than Permitted Liens), and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

Appears in 1 contract

Sources: Securities Purchase Agreement (Surgalign Holdings, Inc.)